REGISTRATION FOR ABCD DIABETES UPDATE 2024 IS NOW CLOSED!
31st January - 2nd February 2024.
The Diabetes Update programme is a new initiative for trainees in diabetes and endocrinology. It aims to cover the diabetes section of the training curriculum for diabetes and endocrinology issued by the Joint Royal Colleges of Physicians Training Board. It is also a great opportunity for more established clinicians to find out the latest updates in the area of diabetes.
ABCD has been working with the In-Patient Diabetes lead for Diabetes UK, Prof Gerry Rayman, and a group of Specialists in Diabetes to produce much needed guidance describing the maintenance and delivery of specialist diabetes services during COVID-19.
The document is intended for those involved in delivering and redesigning diabetes services in the light of this pandemic. It recognises the importance of maintaining certain elements of the diabetes service which will be essential in reducing the burden on hospitals and supporting inpatient teams.
Save the date for the ABCD Consultant Development Programme (CDP) 2024. This course is designed to provide SpRs and newly appointed consultants with the opportunity to explore the non-clinical aspects and challenges of being both a leader and a clinician. The ABCD CDP, which has replaced the YDEF-led King's Fund Management Course, is a five-day residential programme and will be held from the 14th October to the 18th October 2024 in Birmingham. Further details will be released shortly.
NHS England piloted a Low Calorie Diet (LCD) programme, delivered through Total Diet Replacement (TDR) and behaviour change support via 1:1, group or digital delivery, to improve Type 2 Diabetes in adults with excess weight. The impact and implementation of this pilot required evaluation to inform longer-term commissioning decisions.
Predictors of response to injectable once-weekly Semaglutide: Insights from the Association of British Clinical Diabetologists nationwide audit
Authors:
Thomas SJ Crabtree< Karen Adamson, Alex Bickerton, Alison Evans, Suzanne Phillips, Alison Gallagher, Niels Larsen, Dennis Barnes, Ketan Dhatariya, Benjamin CT Field, Iskandar Idris, Robert EJ Ryder on behalf of all ABCD Semaglutide audit contributor
